Surprisingly, however, when tumour development and growth were assessed at days 56 and 64 post‐AOM/DSS treatment, a significantly reduced number and size of colorectal tumours was noticed in SHP‐deficient animals (Fig. 3E–H). Here, NR0B2 is linked to colorectal neoplasm.